MedTrace Logo

Alzheimer's Disease Genetics Study

NCT00064870 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2025-10-01

No results posted yet for this study

Summary

The purpose of the Alzheimer's Disease Genetics Study is to identify the genes that are responsible for causing Alzheimer's Disease (AD). One of the ways in which the risk factor genes for late onset AD can be investigated is by identifying and collecting genetic material from families with multiple members diagnosed with AD or dementia.

Conditions

  • Alzheimer Disease
  • Late Onset Alzheimer Disease
  • Dementia

Sponsors & Collaborators

  • National Institute on Aging (NIA)

    collaborator NIH

  • Indiana University

    lead OTHER

Principal Investigators

  • Tatiana M. Foroud, PhD · National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD), Indiana University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-06-30
Primary Completion
2026-07-31
Completion
2026-07-31

Countries

  • United States

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00064870 on ClinicalTrials.gov